Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
AusPAR: Galcanezumab
Australian Public Assessment Report
Device/Product Name
Emgality
Active ingredients
Galcanezumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2018-00780-1-1
Submission Type
New biological entity
Decision
Approved